Efficacy of SGLT2 Inhibitors in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Preclinical Studies
This systematic review and meta-analysis of nine preclinical studies demonstrates that SGLT2 inhibitors significantly improve pulmonary hemodynamics and right ventricular function in animal models of pulmonary arterial hypertension, suggesting their potential as a novel therapeutic strategy.